From Africa to Ukraine: one year later, ALIMA continues its emergency medical aid in Ukrainian conflict zones
ALIMA (The Alliance for International Medical Action) is a medical humanitarian organization based in Dakar, Senegal, that has been saving lives since 2009 in emergency situations in Africa.
ALIMA’s unique model focuses on building alliance and promoting collaboration between local health workers, national medical organizations, and researchers. ALIMA strives to transform humanitarian medicine by fostering research and innovation to improve care and help communities prepare for the future. ALIMA has treated more than 10 million patients in 14 countries, and launched more than 30 research projects – notably on malnutrition, maternal and child health, malaria, Ebola and COVID-19. This work has won several international awards such as the Game-Changing Innovator REACH Award and the EU Health Award .
ALIMA participates in Ebola vaccine trial with promising results
The results of a large-scale clinical trial in West Africa, confirming the safety of three different Ebola vaccine regimens, have been published in the New England Journal of Medicine. ALIMA’s in-field support in Guinea has been crucial to the implementation of the trial.
Burkina Faso: Almost 2 million people displaced
Nearly one in 10 people in Burkina Faso have been displaced by conflict. Most worryingly, the rate of severe food insecurity has nearly doubled compared to last year, with over 600,000 people in emergency hunger levels during this lean season, warn 28 international aid organisations operating in the country. An urgent increase in funding for humanitarian assistance is required to respond to the current situation.
ALIMA responds to new outbreak of Ebola in the Democratic Republic of the Congo
Dakar/Mbandaka – Medical humanitarian organization ALIMA (The Alliance for International Medical Action) is responding to a new outbreak of Ebola in the Democratic Republic of the Congo (DRC). Working alongside local health authorities, the organization plans to help manage the outbreak, drawing from its extensive experience responding to Ebola outbreaks in the region over the past years.
In Mauritania, ALIMA brings COVID-19 vaccinations closer to vulnerable populations
Mauritania has one of the highest immunization rates in sub-Saharan Africa, yet there are isolated and remote communities that are unlikely to access vaccination. To reduce these inequities, ALIMA supports the deployment of mobile teams that travel to villages to meet the population and vaccinate them directly on site.
Doctors battle Lassa fever outbreak in Nigeria
Medical humanitarian NGO ALIMA (The Alliance for International Medical Action) is fighting a silent epidemic of Lassa fever, an acute viral hemorrhagic illness similar to Ebola. More funding for research is urgently required to better understand and treat this neglected tropical disease.
“COVID-19: In Africa, we must reassure the public about the benefits of vaccination”.
While a 5th wave of COVID-19 is hitting Western countries with full force, in Africa, where the vaccination rate is very low, the epidemic is on the rise again. Faced with the upcoming risk and in the wake of the last few months, Richard Kojan, President of ALIMA since 2015 and a resuscitator-anesthesiologist, shares his point of view on the current health situation on the continent. He gives us a level-headed, optimistic testimony from an expert’s point of view.
COVID-19 in Senegal: The needs to fight the pandemic are significant
Interview with Dr. Charles Tehoua, Emergency Medical Coordinator for ALIMA (The Alliance for International Medical Action).
Burkina Faso: Facilitating access to care for the elderly
The listening, leisure and care center within Burkina Faso’s National Center for the Elderly (CNPA) is a unique space. Located in the health district of Bogodogo in the capital city, Ouagadougou, it is one of the few facilities in the country that offers activities for the elderly.
VACCINATION FOR AFRICA
As a third wave of COVID-19 spreads across the continent, less than 2% of the African population has received the first dose of a COVID-19 vaccine. This situation is particularly alarming.
